OpenScience.ink

2 weeks ago • Obesity surgery

Cost-effectiveness of minimally invasive weight loss treatments compared to sleeve stomach surgery and semaglutideCost-Effectiveness of Endoscopic Bariatric Therapies Compared with Laparoscopic Sleeve Gastrectomy and Semaglutide.

📖 Top 20% Journal

2 weeks ago • The Journal of clinical endocrinology and metabolism

How Blood Sugar and Body Weight Levels Affect Heart Benefits of Oral Semaglutide in the SOUL TrialOral Semaglutide and CV Benefits in the SOUL Trial: How Do Baseline or Changes in HbA1c or BMI Affect Clinical Outcomes?

🥉 Top 5% Journal

2 weeks ago • PloS one

How two diabetes drugs may differ in their link to osteoarthritis riskComparative effects of SGLT2 inhibitors and GLP-1 receptor agonists on osteoarthritis risk in patients with type 2 diabetes mellitus: A multi-institutional cohort study.

📖 Top 30% Journal

2 weeks ago • Diabetologia

Drug treatment for metabolic dysfunction-associated fatty liver diseasePharmacological treatment of MASH.

🥈 Top 2% Journal

2 weeks ago • Frontiers in endocrinology

Heart protection from incretin therapies beyond diabetes: evidence, how they work, and new treatment options from GLP-1 drugs to combined therapiesIncretin-based cardiovascular protection beyond diabetes: evidence, mechanisms, and therapeutic frontiers from GLP-1 receptor agonists to multi-agonist therapy.

🎖️ Top 10% Journal

2 weeks ago • British journal of clinical pharmacology

Semaglutide compared to liraglutide and their links to diabetes and heart disease in real-world dataSemaglutide vs. liraglutide and incidence of diabetes and cardiovascular disease: A target trial emulation using real-world data.

📖 Top 20% Journal

2 weeks ago • The Journal of clinical endocrinology and metabolism

GLP1R gene variations are linked to insulin release and sensitivity in obese children and teensGLP1R haplotypes are associated with insulin secretion and sensitivity in children and adolescents with obesity.

🥉 Top 5% Journal

2 weeks ago • Frontiers in endocrinology

Tirzepatide and lower risk of blood clots in lungs and veins: a U.S. multi-center studyTirzepatide and reduced risk of pulmonary embolism and deep vein thrombosis: a multicenter U.S. cohort study.

🎖️ Top 10% Journal

3 weeks ago • Nutrients

Preventing and Managing Iron Deficiency Linked to Treatments That Boost Incretin HormonesIroning Out Possible Micronutrient Deficiencies Associated with Incretin Receptor Agonist-Based Therapies: Proposed Practical Strategies to Prevent and Manage Iron Deficiency.

🎖️ Top 10% Journal

3 weeks ago • International journal of molecular sciences

Possible Benefits of Glucagon-like Peptide-1 Receptor Drugs for Breathing ProblemsTherapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Respiratory Disorders.

📖 Top 20% Journal

3 weeks ago • Frontiers in endocrinology

Latent autoimmune diabetes in two young women treated with oral semaglutide and long-acting insulinCase Report: Latent autoimmune diabetes in two young female patients successfully treated with oral semaglutide and basal insulin.

🎖️ Top 10% Journal

3 weeks ago • International journal of molecular sciences

Low Gut Hormones and Tirzepatide as a Multi-Target Approach in Hard-to-Treat Endometriosis Linking Metabolism, Immunity, Tissue Scarring, and PainPeritoneal Incretin Deficiency and Tirzepatide as a Multi-Axis Adjuvant Hypothesis in Treatment-Refractory Endometriosis: A Mechanistic Framework Linking Metabolism, Immunity, Fibrosis, and Nociception.

📖 Top 20% Journal

3 weeks ago • Diabetes/metabolism research and reviews

Link Between New Diabetes Drugs and Atrial Fibrillation Risk in Type 2 Diabetes Patients: Combined Analysis of StudiesNetwork and Pairwise Meta-Analysis of the Association Between Novel Hypoglycemic Agents and Atrial Fibrillation Risk in Patients With Type 2 Diabetes Mellitus.

🎖️ Top 10% Journal

3 weeks ago • Journal of clinical medicine

Insulin Glargine/Lixisenatide's 12-Month Effects on Weight, Natural Insulin Production, and Kidney Health Beyond Blood Sugar ControlBeyond Glycemic Control: Real-World 12-Month Effects of Insulin Glargine/Lixisenatide on Weight, Endogenous Insulin Secretion, and Albuminuria.

📖 Top 20% Journal

3 weeks ago • Nutrients

A Plant-Based Treatment That Activates Two Key Metabolic Paths May Improve Obesity and Metabolism in Lab ModelsDual Activation of GLP-1 and AMPK Pathways by a Multi-Botanical Formulation Improves Obesity and Metabolic Dysfunction in Experimental Models.

🎖️ Top 10% Journal

3 weeks ago • Journal of clinical medicine

Semaglutide as a useful treatment for irregular periods and lack of ovulation in women with polyendocrine metabolic ovarian syndromeEvidence That Semaglutide Represents an Important Tool for Treatment of Irregular Menses and Chronic Anovulation in Women with Polyendocrine Metabolic Ovarian Syndrome.

📖 Top 20% Journal

3 weeks ago • Journal of clinical medicine

Changes in Blood Sugar-Regulating Hormones During Endurance Training in Competitive TriathletesChanges in GLP-1 and GIP During Endurance Training in Competitive Triathletes: A Pilot Observational Study.

📖 Top 20% Journal

3 weeks ago • The Journal of clinical endocrinology and metabolism

Differences between people in stomach emptying relate to GLP-1 hormone response after sugar enters the small intestine in healthy individualsInter-individual variation in gastric emptying is related to GLP-1 response to intraduodenal glucose exposure in health.

🥉 Top 5% Journal

3 weeks ago • eLife

The Crunchometer: An inexpensive, open tool to analyze detailed chewing soundsThe Crunchometer, a low-cost, open-source acoustic analysis of feeding microstructure.

🥈 Top 2% Journal

3 weeks ago • Cells

Liraglutide Strongly Protects Pancreatic Cells from Injury Linked to Blocking HMGB1 ReleaseLiraglutide Potently Protects Against Streptozotocin-Induced Islet Injury Associated with Inhibition of HMGB1 Release.

🎖️ Top 10% Journal

3 weeks ago • Translational psychiatry

Effects of activating the glucagon-like peptide-1 receptor on mental health using genetic analysisGlucagon-like peptide-1 receptor activation and mental health: a drug-target mendelian randomization study.

🥉 Top 5% Journal

3 weeks ago • Journal of gastroenterology and hepatology

Comparing Combined GLP-1 and SGLT2 Treatments to Single Therapy in Fatty Liver Disease and Type 2 DiabetesGLP-1 RA Plus SGLT2i Versus Monotherapy in MASLD and Type 2 Diabetes: Three Pairwise Target Trial Emulations.

📖 Top 20% Journal

3 weeks ago • Journal of endocrinological investigation

Comparing the effects of injected GLP-1 drugs and SGLT2 inhibitors on metabolism and liver health in type 2 diabetes with fatty liverComparative effectiveness of subcutaneous GLP-1 receptor agonists versus SGLT2 inhibitors on metabolic and hepatic outcomes in T2DM with MASLD: a propensity score-matched study.

📖 Top 20% Journal

3 weeks ago • Cardiovascular diabetology

Heart health outcomes of combining empagliflozin and GLP-1RA in type 2 diabetesCardiovascular outcomes of empagliflozin-GLP-1RA combination therapy in type 2 diabetes: EMPRISE study.

🥈 Top 2% Journal

3 weeks ago • Biology methods & protocols

Using large language models to improve tracking of starting, continuing, and combining glucagon-like peptide-1 treatments from clinical notes beyond prescriptionsAuditable large language model curation of clinical notes refines glucagon-like peptide-1 initiation, persistence ascertainment, and compounding use beyond prescription records.

📖 Top 30% Journal

3 weeks ago • The Medical journal of Australia

Weight Loss Drug Marketing and First Nations People: Focus on Health Awareness or Company Profit?Weight Loss Medication Marketing and First Nations People: Disease Awareness or Corporate Profit?

🎖️ Top 10% Journal

3 weeks ago • Frontiers in endocrinology

How fat location affects metabolism: biology, health measures, and treatment approachesAdipose tissue distribution in metabolic disease: depot-specific biology, clinical assessment, and therapeutic remodeling.

🎖️ Top 10% Journal

3 weeks ago • Alcohol, clinical & experimental research

Links Between Prescriptions of a Diabetes Drug and Alcohol Drinking in a Large U.S. Health StudyAssociation of GLP-1 Receptor Agonist Prescriptions and Alcohol Consumption in the National Institutes of Health's All of Us Cohort.

📖 Top 20% Journal

3 weeks ago • Frontiers in endocrinology

Big metabolic improvement with tirzepatide in a patient with partial fat loss after stem cell transplantCase Report: Dramatic metabolic improvement with tirzepatide in a patient with acquired partial lipodystrophy following hematopoietic stem cell transplantation.

🎖️ Top 10% Journal

4 weeks ago • Translational psychiatry

Comparing weight loss drugs that target blood sugar control in people with mental illnessGlucagon-like peptide-1 receptor agonists for weight management in mental illness: a network meta-analysis.

🥉 Top 5% Journal

← prevpage 3 of 14next →

GLP-1 Therapies Research Papers